Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre-Reference-Cited by-同舟云学术

Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre

Published:2013-07-01 Issue:7 Volume:17 Page:934-939
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Shu C-C.¹,Lee C-H.²,Lee M-C.³,Wang J-Y.⁴,Yu C-J.⁴,Lee L-N.⁵

Affiliation:

1. Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

2. Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan

3. Department of Pharmacy, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan

4. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

5. Department of Internal Medicine and Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

2. A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing;American Journal of Respiratory and Critical Care Medicine;2024-06-15

3. A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing;2023-09-10

4. Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?;PLOS ONE;2023-05-31

5. Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2023-03-01